Crossmark

Cardiomyocyte-restricted high-mobility group box 1 (HMGB1) deletion leads to small heart and glycolipid metabolic disorder through GR/PGC-1α signalling

Crossref DOI link: https://doi.org/10.1038/s41420-020-00340-9

Published Online: 2020-10-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Peng https://orcid.org/0000-0003-4942-7139
Liu, Ming

Zhang, Baoli

Yu, Ying

Su, Enyong

Xie, Shiyao

Zhang, Lei

Yang, Xue

Jiang, Hong https://orcid.org/0000-0002-7260-9646
Chen, Ruizhen

Zou, Yunzeng

Ge, Junbo
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81670355)

National Natural Science Foundation of China (81970375)

National Natural Science Foundation of China (81800376)

National Natural Science Foundation of China (81600294)

National Natural Science Foundation of China (81521001)
License Information

Text and Data Mining valid from 2020-10-20

Version of Record valid from 2020-10-20
More Information

Article History

Received: 10 July 2020

Revised: 13 September 2020

Accepted: 24 September 2020

First Online: 20 October 2020

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below